Shamma Almuraikhy | drug design | Best Researcher Award

Dr. Shamma Almuraikhy | drug design | Best Researcher Award

Senior research assistant, Qatar university, Qatar

Shamma Abdullah AL Muraikhy is a distinguished Qatari academic and researcher currently working as a Senior Research Assistant at the Biomedical Research Centre at Qatar University. With a background in clinical laboratory sciences, Shamma has dedicated her career to advancing research in the fields of exercise science, insulin resistance, and type 2 diabetes. She holds a Ph.D. in Drug Design from the University of Groningen (Netherlands), a Master of Science from the University of Bristol (UK), and a Bachelor’s degree in Clinical Laboratory Sciences from Imam Abdulrahman Bin Faisal University (Saudi Arabia). Her research work focuses on molecular techniques, including metabolomics, and its applications in insulin resistance and other metabolic disorders. She has contributed significantly to several research projects and publications, making her an expert in her field. 🧑‍🔬📚

Publication Profile

Google Scholar

Education:

Shamma holds a Ph.D. in Drug Design from the University of Groningen, Netherlands (2021–2024). Her Master’s in Science was obtained from the University of Bristol, UK (2015–2017). She completed her Bachelor’s in Clinical Laboratory Sciences (Formerly Medical Laboratory Technology) at Imam Abdulrahman Bin Faisal University (Saudi Arabia) between 1993 and 1997. 🎓🌍

Experience:

Shamma’s professional career spans over two decades, beginning with her work as a Medical Lab Technologist at King Fahd Teaching Hospital (Saudi Arabia) in 1998. She later worked as a Senior Lab Technologist at ARAMCO Hospital (Saudi Arabia). Over the years, Shamma held various significant roles, including Senior Research Scientist and Risk & Quality Officer at the Anti-Doping Lab in Qatar. Currently, she serves as a Senior Research Assistant at the Biomedical Research Centre, Qatar University. 🏥🔬

Awards and Honors:

Shamma’s academic and research contributions have earned her numerous accolades. These include multiple research grants and honors, such as being a prominent investigator in several national research projects on insulin resistance, diabetes, and exercise science. Her work is highly regarded in her field, with her publications cited in several international journals. 🏆✨

Research Focus:

Shamma’s research is at the intersection of exercise science, molecular biology, and metabolic disorders. Her primary research focus includes investigating insulin resistance, adipogenesis, and diabetes. She has explored various molecular mediators involved in exercise-induced insulin sensitivity and the role of inflammatory biomarkers and oxidative stress in athletes. She is also focused on understanding how exercise and fasting may influence telomere length and cellular aging, and her work on GATA-3 as a potential therapeutic target for insulin resistance is groundbreaking. 🔬💪

Conclusion:

Shamma Abdullah AL Muraikhy is a leading researcher in the fields of exercise science and metabolic health. With a robust academic background, extensive professional experience, and a passion for improving our understanding of insulin resistance and diabetes, Shamma continues to make significant contributions to scientific research. Her work is poised to influence future therapeutic strategies and interventions for metabolic diseases. 🌟📈

Publications:

Metabolic signature of leukocyte telomere length in elite male soccer players
Shamma Al-Muraikhy, Maha Sellami, Alex Domling, et al.
Front. Mol. Biosci., December 2021, Vol. 8
Link to publication

High endurance elite athletes show age-dependent lower levels of circulating complements compared to low/moderate endurance elite athletes
Shamma Al-Muraikhy, Manjunath Ramanjaneya, Alexander S. Dömling, et al.
Front. Mol. Biosci., September 2021, Vol. 8
Link to publication

Molecular regulators of exercise-mediated insulin sensitivity in non-obese individuals (review paper)
Shamma AlMuraikhy, Asmaa Doudin, Alexander Domling, et al.
J Cell Mol Med, 2023
Link to publication

Comparing the Metabolic Profiles Associated with Fitness Status between Insulin-Sensitive and Insulin Resistant Non-Obese Individuals
Shamma AlMuraikhy, Najeha Anwardeen, Aisha Naeem, et al.
Int. J. Environ. Res. Public Health, 2022, 19(19), 12169
Link to publication

The Metabolic Switch of Physical Activity in Non-Obese Insulin Resistant Individuals
Shamma Almuraikhy, Najeha Anwardeen, Asmma Doudin, et al.
Int. J. Mol. Sci., 2023, 24(9), 7816
Link to publication

Antioxidative Stress Metabolic Pathways in Moderately Active Individuals
Shamma Almuraikhy, Najeha Anwardeen, Asmaa Doudin, et al.
Metabolites, September 2023, 13(9): 973
Link to publication

Impact of Moderate Physical Activity on Inflammatory Markers and Telomere Length in Sedentary and Moderately Active Individuals with Varied Insulin Sensitivity
Shamma Almuraikhy, Maha Sellami, Hadaia Saleh Al-Amri, et al.
J Inflamm Res., 2023, 16: 5427-5438
Link to publication

Eight weeks of aerobic exercise, but not four, improves insulin sensitivity and cardiovascular performance in young women
Maha Sellami, Shamma Almuraikhy, Khaled Naja, et al.
Submitted

Joint Effects of Exercise and Fasting on Telomere Length: Implications for Cellular Aging
Shamma Almuraikhy, Maha Sellami, Khaled Naja, et al.
Biomedicines, May 2024, 12(6): 1182
Link to publication

Metabolic signatures of combined exercise and fasting: An expanded perspective on previous telomere length
Shamma Almuraikhy, Khaled Naja, Najeha Rizwana Anwardeen, et al.
Frontiers
Link to publication

Dr. Lakshmanan Govindan | Pharmacology | Best Researcher Award-1654

Dr. Lakshmanan Govindan | Pharmacology | Best Researcher Award

Dr. Lakshmanan Govindan, Assistant Professor, Saveetha Medical College and Hospital, India

Dr. G. Lakshmanan is a dedicated Assistant Professor and researcher with a strong foundation in Botany. His expertise spans bioactive compound isolation, anticancer activities, and bio-degradation processes. He has a deep passion for scientific exploration, particularly focusing on medicinal plants and nanotechnology applications. With a career rooted in both academic and scientific advancements, Dr. Lakshmanan aims to contribute to educational growth and cutting-edge research.

Profile

Scopus

Strengths for the Award

Dr. G. Lakshmanan has a strong academic and research background, with a Ph.D. in Botany and expertise in bioactive compounds from medicinal plants, anticancer activities, and nanotechnology applications. His work includes published papers with significant impact factors and several patents, reflecting innovation in medicinal plant research. His professional experience spans multiple institutions, and he has also served as a reviewer for national and international bodies. His receipt of the Young Scientist Award further highlights his research excellence.

Areas for Improvement

While Dr. Lakshmanan’s research is commendable, more focus on international collaborations and interdisciplinary projects could further enhance his profile. Additionally, expanding his research beyond plant-based studies may add more diversity to his work.

🎓 Education

Dr. Lakshmanan completed his Ph.D. in Botany from the University of Madras in 2019, where his research focused on antiproliferative bioactive compounds. Prior to that, he earned his M.Phil. (2012) and M.Sc. (2011) degrees in Botany, also from the University of Madras and Madurai Kamaraj University, respectively, solidifying his expertise in plant biology and its applications.

👨‍🏫 Experience

Dr. Lakshmanan currently serves as an Assistant Professor at Saveetha Medical College & Hospital, Chennai. His prior roles include positions at Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry, and Bharath Institute of Higher Education and Research. His academic journey is complemented by his experience as a Junior Scientist at Meenakshi Academy of Higher Education, where he honed his research skills in medicinal plant bioactivity.

🔬 Research Interests

Dr. Lakshmanan’s research interests include the isolation of bioactive compounds from medicinal plants, focusing on anticancer and antidiabetic activities. He is also passionate about biosynthesis of nanoparticles, larvicidal activities, plant tissue culture, and the biodegradation of textile dyes. His work strives to explore the natural world’s potential for sustainable and impactful solutions.

🏆 Awards

Dr. Lakshmanan has been recognized with the prestigious Young Scientist Award by the INSO Awards for his significant contributions to science, technology, and management. His dedication to research and education continues to earn him accolades in both national and international spheres.

📚 Publication Top Notes

Nongthombam, K.S. et al. (2024). “Biogenic Production of Silver Nanoparticles Using Neocosmospora Solani Endophytic Fungal Extract: Their In Vitro Antibacterial and Anticancer Properties.” Journal of Inorganic and Organometallic Polymers and Materials. [Cited by 12 articles]. Read here.

Kamakshi, S. et al. (2024). “Antibacterial and Photo Dye Degradative Ability of Copper Oxide Nanoparticles from Pleurotus Cystidiosus.” IOP Nano Express. [Cited by 8 articles]. Read here.

Lakshmikanthan, M. et al. (2024). “A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications.” Journal of Agriculture and Food Research. [Cited by 10 articles]. Read here.

Muthu, S. et al. (2024). “Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis Procera.” European Food Research and Technology. [Cited by 6 articles]. Read here.

Vijayaraj, R. et al. (2024). “Chitin-Derived Silver Nanoparticles for Enhanced Food Preservation: Synthesis, Characterization, and Applications.” European Food Research and Technology. [Cited by 7 articles]. Read here.

Conclusion

Dr. Lakshmanan’s expertise, awards, and academic contributions make him a strong candidate for the Best Researcher Award. With a broader interdisciplinary approach, his already impressive work could gain even greater recognition.